Perspective Therapeutics (CATX) Assets Average (2011 - 2026)

Perspective Therapeutics has disclosed Assets Average across 15 years of filings, most recently posting $338.9 million for Q1 2026.

• Assets Average for Q1 2026 came in at $338.9 million, up 1.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $338.9 million (up 1.09% YoY), and the FY2025 annual result was $304.0 million, up 38.52% from the prior year.
• Assets Average came in at $338.9 million for Q1 2026 at Perspective Therapeutics, up from $280.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $388.5 million in Q3 2024 to a low of $60.3 million in Q4 2022.
• The 5-year median for Assets Average is $188.1 million (2024), against an average of $208.5 million.
• Across the five-year window, Assets Average soared 251.35% in 2024 and slipped 23.28% in 2025, its largest moves.
• Perspective Therapeutics' Assets Average stood at $60.3 million in 2022, then soared by 72.77% to $104.2 million in 2023, then jumped by 251.35% to $366.1 million in 2024, then fell by 23.28% to $280.9 million in 2025, then advanced by 20.64% to $338.9 million in 2026.
• The last three Assets Average figures came in at $338.9 million (Q1 2026), $280.9 million (Q4 2025), and $302.8 million (Q3 2025), per Business Quant data.